LO Funds - Swiss Equity (CHF) MDRegister to Unlock Ratings |
Performance History | 29/02/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 11.5 | 21.5 | -12.7 | 7.1 | -1.0 | |
+/-Cat | 1.0 | 1.5 | -3.9 | -3.9 | 0.5 | |
+/-B’mrk | - | -0.8 | -5.5 | -1.6 | 0.5 | |
Category: Switzerland Equity | ||||||
Category Benchmark: Morningstar Switzerland TME... |
Key Stats | ||
NAV 27/03/2024 | CHF 16.69 | |
Day Change | -0.05% | |
Morningstar Category™ | Switzerland Equity | |
ISIN | LU1079728462 | |
Fund Size (Mil) 27/03/2024 | CHF 203.43 | |
Share Class Size (Mil) 27/03/2024 | CHF 11.67 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 06/02/2024 | 1.18% |
Investment Objective: LO Funds - Swiss Equity (CHF) MD |
The Sub-Fund is actively managed. The SPI TR index is used to define the initial investment universe for individual security selection, for performance comparison as well as for internal risk monitoring purposes, without implying any particular constraints to the Sub-Fund's investments. The Sub-Fund’s securities will generally be similar to those of the above-mentioned index but the security weightings are expected to differ materially. The Investment Manager may also select securities not included in the above-mentioned index in order to take advantage of investment opportunities. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Johan Utterman 18/11/2015 | ||
Fabian Weiderin 27/02/2020 | ||
Inception Date 29/08/2014 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
SIX SPI TR CHF | Morningstar Switzerland TME NR CHF |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for LO Funds - Swiss Equity (CHF) MD | 31/01/2024 |
|
|
Top 5 Holdings | Sector | % |
Nestle SA | Consumer Defensive | 9.73 |
Roche Holding AG | Healthcare | 9.51 |
Novartis AG Registered Shares | Healthcare | 9.19 |
UBS Group AG | Financial Services | 5.30 |
Holcim Ltd | Basic Materials | 4.70 |
Increase Decrease New since last portfolio | ||
LO Funds - Swiss Equity (CHF) MD |